Switzerland’s legacy in R&D is a success story and ideal starting place to build on its leading position. Jörg highlights the key success factors Swiss based pharmaceutical companies need to address to turn this opportunity into a reality: trust, diversity – also in trial groups – data access, digitization and patient centricity.
